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229 
About 70% of bladder cancers are superficial at the initial state. If diagnosed at an early stage， 
the tumor may be resected completely and easily. However， recurrence is seen in many cases. 
Prognostic factors of recurrence were investigated in 55 cases of bladder cancer newly diagnosed 
(excluding carcinoma in situ) between 1995 and 2003， and in which complete resection by transurethral 
resection (TUR) was possible at first recurrence after initial TUR. One-and three幽yearpost-
operative non-recurrence rates were 5l.9% and 36.3%， respectively. None ofthe factors studied， i.e.， 
stage， grade， tumor multiplicity (at initial and at first recurrence)， change of stage and grade at first 
recurrence compared with that ofinitial TUR， duration to recurrence and adjuvant therapy after TUR， 
were found to inftuence the prognosis a氏errecurrence. Similar results were obtained for third TUR. 
Recurred pTa， grade 1 or solitary cancer at initial or at recurrence had the same prognosis as pTl， 
grade 2-3 or multiple cancers， and careful follow-up is needed. 
(Hinyokika Kiyo 51: 229-233， 2005) 
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緒 Fコ
勝脱癌は，尿路性器癌の中では前立腺癌に次いで多
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Fig. 1. Non-recurrence rate in cases with 
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Fig. 2. Non問recurrencerate according to tu-
mor stages in cases with recurrent 
superficial bladder cancer (a-pT at 
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Fig. 3. Non-recurrence rate according to tu-
mor grade in cases with rccurrent 
superficial bladder cancer (a-gr.1巾 at





初回再発時の異型度は， grade 1 13例 (23.6%)， 
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Fig. 4. Non-recurrence rate according to the 
number of tumors in cases with recur-
rent superficial bladder cancer (a幽the
number of tumors at primary， b-the 
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Fig. 5. Non-recurrence rate according to 
changes of tumor stages in cases with 
recurrent superficial bladder cancer. 
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Fig. 6. Non-recurrence rate according to 
changes of tumor grades in cases with 




















注入28例 (50.9%)，BCG腸脱内注入4例 (7.3%)， 
局所照射+抗癌剤動脈内注入 l例(1.8%)であった.
術後補助療法の有無別にみた初回再発後の予後を
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Fig. 8. Non-recurrence rate according to post-
operative prophylactic treatment in 





























4. 初発時および再発時に pTa，grade 1あるいは
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